Cocoon Bioscience
Pre-clinicalCocoon Bioscience’s recombinant protein expression system uses natural bioreactors to produce affordable, scalable, and effective products.
Founded
2019
Focus
BiologicsMicrobiome
About
Cocoon Bioscience’s recombinant protein expression system uses natural bioreactors to produce affordable, scalable, and effective products.
Funding History
1Total raised: $1.5M
Seed$1.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2019
LocationMadrid, Spain
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile